Y-Intercept (HK)’s AdaptHealth AHCO Stock Holding History

Y-Intercept (HK)’s Portfolio AHCO Stock Details AHCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,495	Closed	-$114K	–	1604
2025 Q1	$114K	Buy	+10,495	New	+$106K	0.01%	1106
2024 Q2	–	Sell	-38,091	Closed	-$438K	–	1344
2024 Q1	$438K	Buy	38,091 +15,296	+67%	+$130K	0.03%	776
2023 Q4	$166K	Buy	+22,795	New	+$180K	0.02%	1034
2023 Q2	–	Sell	-12,398	Closed	-$154K	–	1230
2023 Q1	$154K	Buy	+12,398	New	+$228K	0.02%	1008

Other funds holding AHCO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OCA

OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Y-Intercept (HK)'s AHCO Position: Q2 2025 in Review

Y-Intercept (HK) sold out of AdaptHealth (AHCO) in Q2 2025, closing a stake of 10,495 shares — an estimated $114K sold.

Y-Intercept (HK) first reported a position in AHCO in Q1 2023 and held it in 4 quarters. The position peaked at $438K in Q1 2024. 218 funds tracked by Wall St. Rank hold AHCO as of Q2 2025.

Y-Intercept (HK) reported no remaining AdaptHealth position as of Q2 2025 after selling out during the quarter.
Y-Intercept (HK) sold 10,495 AdaptHealth shares in Q2 2025, an estimated $114K.
Y-Intercept (HK) first reported a position in AdaptHealth in Q1 2023 and held it in 4 quarters.
Y-Intercept (HK)'s AdaptHealth position peaked at $438K in Q1 2024.
218 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2025.

Based on Y-Intercept (HK)'s 13F filing for Q2 2025, filed 1 Aug 2025.